Article

Modular Medical, Inc. announced a public offering of 68,098,000 shares and warrants priced at $0.1762, expecting gross proceeds of approximately $12 million. The offering, closing on or about March 4, 2026, is managed by Maxim Group LLC and includes participation from both new and existing investors.

The company is currently trading at $0.13, reflecting a 67% decline over the past week. Modular Medical is also producing validation lots for its Pivot tubeless patch pump, with a commercial launch projected for Q1 2026, pending FDA clearance.

Additionally, the company has increased authorized shares from 100 million to 250 million and secured a $350,000 revolving credit facility from CEO James E. Besser, maturing on March 25, 2026. Modular Medical received a 180-day extension from Nasdaq to comply with minimum bid price requirements by June 29, 2026.